Evidence map›Paper›PMID 40901382›Full record

ArticleBJR open2025

Development of a biological at-risk volume using apparent diffusion coefficient for parotid-sparing radiation therapy planning.

Katelyn Cahill, Catriona Hargrave, Patrick O'Connor, Mark Denham, Nathan Hearn, Dinesh Vignarajah, Zack Y Shan, Myo Min

Abstract read
In one paragraph

Article in BJR open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katelyn CahillAdem Crosby Centre-Radiation Oncology, Sunshine Coast University Hospital, Birtinya, QLD 4575, Australia.ORCID https://orcid.org/0000-0001-9371-3285
Catriona HargraveRadiation Oncology Princess, Alexandra Hospital Raymond Terrace, Brisbane, QLD 4101, Australia.
Patrick O'ConnorAdem Crosby Centre-Radiation Oncology, Sunshine Coast University Hospital, Birtinya, QLD 4575, Australia.
Mark DenhamDepartment of Medical Imaging, Sunshine Coast University Hospital, Birtinya, QLD 4575, Australia.
Nathan HearnThompson Institute, University of the Sunshine Coast, Birtinya, QLD 4575, Australia.
Dinesh VignarajahAdem Crosby Centre-Radiation Oncology, Sunshine Coast University Hospital, Birtinya, QLD 4575, Australia.
Zack Y ShanThompson Institute, University of the Sunshine Coast, Birtinya, QLD 4575, Australia.
Myo MinAdem Crosby Centre-Radiation Oncology, Sunshine Coast University Hospital, Birtinya, QLD 4575, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Xerostomia toxicity continues to contribute towards a decrease in quality of life in head and neck cancer patients. Diffusion weighted MRI and the associated apparent diffusion coefficient (ADC) may identify the radiosensitive region within the parotid gland (PG). This study retrospectively assesses the feasibility of using percentile threshold values from the ADC map to generate a biological at-risk volume (BRV). The location and distribution of BRV are evaluated across the PG. Methods: Image registration between the planning CT and MRI-simulation images was performed and reviewed to ensure accurate translation of ADC data when contouring the PG. Histogram analysis was undertaken using the 20th, 30th, and 50th percentile ADC values of each contoured PG to form the BRV. The whole PG was split into 8 anatomical sectors at a common intersection point to evaluate the distribution of BRV throughout. Results: The BRV distribution for each percentile was mapped across the whole contoured PG and each anatomical sector contour. The largest distribution was predominantly found in the superolateral sectors. Conclusions: The 20th and 30th percentile ADC values can be used to form a BRV of the PG. The location of the BRV distribution indicates a potential relationship between ADC thresholds and the functional region of the PG. Advances in knowledge: The BRV is located in a favourable position within the PG and could be used to further spare this salivary gland during dose optimization. The feasibility of this approach will be explored in a future retrospective dosimetry study.

Indexed as

apparent diffusion coefficientbiological at-risk volumediffusion-weighted MRIhead and neck cancerparotid glandradiotherapy

Identifiers

PMID40901382
PMCPMC12401576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.